Skip to main content
    I

    Innospec Inc (IOSP)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ

    $79.17
    -1.22 (-1.52%)

    Market Cap: $1.98B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Innospec Inc (IOSP) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Innospec (IOSP) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Innospec reported EPS of $1.29, above the $1.26 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +10.42%
    Streak
    6 Q

    Upcoming Estimates

    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.45
    Range$1.35 - $1.52
    5 analysts
    Revenue Consensus
    $505.99M
    Range$472.36M - $534.77M
    5 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.40
    Range$1.39 - $1.41
    2 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.51-7.0%
    60d ago$1.51-7.0%
    30d ago$1.51-7.0%
    7d ago$1.47-4.8%
    Current$1.40
    Revenue Consensus
    $497.50M
    Range$491.90M - $503.10M
    2 analysts

    Next Report

    IOSP has an expected report date of Feb 15, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 3.3% below the $1.50 reported for the quarter ended Dec 31, 2025.

    IOSP Earnings Call

    The latest IOSP earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, IOSP beat 34, missed 3 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $473.60M, up 7.2% from $441.90M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.29$1.26$1.24 - $1.29+2.38%Beat+15.2%32 up, 0 downNov 3, 2026$473.60M
    Jun 30, 2026$1.27$1.05$1.03 - $1.06+20.95%Beat+0.8%3N/AAug 4, 2026$491.40M
    Mar 31, 2026$1.05$1.01$0.99 - $1.04+3.96%Beat-26.1%20 up, 1 downMay 7, 2026$453.20M
    Dec 31, 2025$1.50$1.24$1.23 - $1.25+20.97%Beat+6.4%30 up, 2 downFeb 17, 2026$455.60M
    Sep 30, 2025$1.12$1.06$1.03 - $1.09+5.66%Beat-17.0%20 up, 1 downNov 4, 2025$441.90M
    Jun 30, 2025$1.26$1.21$1.17 - $1.25+4.13%Beat-9.4%20 up, 1 downAug 5, 2025$439.70M
    Mar 31, 2025$1.42$1.42$1.39 - $1.460.00%In line-18.9%30 up, 1 downMay 8, 2025$440.80M
    Dec 31, 2024$1.41$1.36$1.35 - $1.37+3.68%Beat-23.4%30 up, 1 downFeb 18, 2025$466.80M
    Sep 30, 2024$1.35$1.35$1.31 - $1.390.00%In line-15.1%30 up, 0 downNov 5, 2024$443.40M
    Jun 30, 2024$1.39$1.37$1.37 - $1.38+1.46%Beat+8.6%30 up, 0 downAug 6, 2024$435.00M
    Mar 31, 2024$1.75$1.64$1.60 - $1.68+6.71%Beat+26.8%31 up, 0 downMay 9, 2024$500.20M
    Dec 31, 2023$1.84$1.62$1.56 - $1.67+13.58%Beat+53.3%30 up, 0 downFeb 13, 2024$494.70M
    Sep 30, 2023$1.59$1.45$1.42 - $1.47+9.66%Beat-8.6%30 up, 1 downNov 7, 2023$464.10M
    Jun 30, 2023$1.28$1.28$1.26 - $1.310.00%In line-19.0%30 up, 0 downAug 8, 2023$480.40M
    Mar 31, 2023$1.38$1.17$1.12 - $1.26+17.95%Beat-9.8%31 up, 0 downMay 3, 2023$509.60M
    Dec 31, 2022$1.20$1.40$1.33 - $1.48-14.29%Miss-7.7%40 up, 0 downFeb 21, 2023$510.70M
    Sep 30, 2022$1.74$1.41$1.36 - $1.49+23.40%Beat+51.3%40 up, 0 downNov 8, 2022$513.00M
    Jun 30, 2022$1.58$1.36$1.30 - $1.45+16.18%Beat+21.5%40 up, 0 downAug 2, 2022$467.60M
    Mar 31, 2022$1.53$1.19$1.15 - $1.22+28.57%Beat+44.3%40 up, 0 downMay 3, 2022$472.40M
    Dec 31, 2021$1.30$1.07$1.01 - $1.07+21.50%Beat+2.4%20 up, 0 downFeb 15, 2022$413.20M
    Sep 30, 2021$1.15$0.96$0.79 - $1.20+19.79%Beat+62.0%31 up, 0 downNov 2, 2021$376.10M
    Jun 30, 2021$1.30$0.89$0.81 - $0.98+46.07%BeatN/A3N/AAug 3, 2021$354.50M
    Mar 31, 2021$1.06$0.99$0.95 - $1.02+7.07%Beat-25.4%2N/AMay 4, 2021$339.60M
    Dec 31, 2020$1.27$0.77$0.64 - $0.78+64.94%Beat-13.6%2N/AFeb 16, 2021$343.50M
    Sep 30, 2020$0.71$0.38$0.29 - $0.39+86.84%Beat-49.3%2N/ANov 3, 2020$265.10M
    Jun 30, 2020-$0.18$0.31N/A-158.06%Miss-116.1%2N/AAug 4, 2020$244.90M
    Mar 31, 2020$1.42$1.23$1.14 - $1.31+15.45%Beat+13.6%3N/AMay 5, 2020$339.60M
    Dec 31, 2019$1.47$1.38$1.35 - $1.41+6.52%Beat-9.3%3N/AFeb 18, 2020$390.70M
    Sep 30, 2019$1.40$1.25$1.16 - $1.37+12.00%Beat+16.7%3N/ANov 5, 2019$371.90M
    Jun 30, 2019$1.12$1.10$1.07 - $1.12+1.82%Beat+12.0%3N/AAug 6, 2019$362.40M
    Mar 31, 2019$1.25$1.18$1.15 - $1.25+5.93%Beat+22.5%3N/AMay 7, 2019$388.30M
    Dec 31, 2018$1.62$1.37$1.32 - $1.43+18.25%Beat+10.2%3N/AFeb 19, 2019$395.00M
    Sep 30, 2018$1.20$1.06$1.02 - $1.09+13.21%Beat+20.0%3N/ANov 6, 2018$363.10M
    Jun 30, 2018$1.00$1.05$0.98 - $1.11-4.76%Miss-13.8%4N/AAug 7, 2018$358.10M
    Mar 31, 2018$1.02$0.92$0.86 - $0.98+10.87%Beat+2.0%3N/AMay 8, 2018$360.70M
    Dec 31, 2017$1.47$1.20$1.10 - $1.34+22.50%Beat+34.9%4N/AFeb 13, 2018$353.80M
    Sep 30, 2017$1.00$0.92$0.85 - $1.05+8.70%Beat+28.2%4N/ANov 7, 2017$332.40M
    Jun 30, 2017$1.16$1.10N/A+5.45%Beat+12.6%2N/AAug 8, 2017$326.30M
    Mar 31, 2017$1.00$0.86N/A+16.28%Beat+7.5%N/AN/AMay 9, 2017$294.30M
    Dec 31, 2016$1.09$0.83N/A+31.33%Beat-12.1%N/AN/AFeb 14, 2017$237.80M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $5.30, down 10.2% from the year before. It was $3.83 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$5.30-10.2%
    Dec 31, 2024$5.90-3.1%
    Dec 31, 2023$6.09N/A
    Dec 31, 2022$6.05+25.8%
    Dec 31, 2021$4.81+49.4%
    Dec 31, 2020$3.22-38.5%
    Dec 31, 2019$5.24+8.3%
    Dec 31, 2018$4.84+4.5%
    Dec 31, 2017$4.63+20.9%
    Dec 31, 2016$3.83N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 2,700 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20262,6606
    2026Q2Jun 30, 20263,7287
    2026Q1Mar 31, 20263,2997
    2025Q4Dec 31, 20255,0727
    2025Q3Sep 30, 20253,0226
    2025Q2Jun 30, 20252,8186
    2024Q4Dec 31, 20242,3875
    2024Q3Sep 30, 20243,3517

    2026Q3 Earnings Call

    Opening remarks

    David Jones General Counsel and Chief Compliance Officer Thank you. Welcome to Innospec's quarterly earnings call. This is David Jones, and I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's filings with the SEC. Please see the SEC site and Innospec's site for these and related documents. In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the company's performance and anticipated impact that these items and events had on financial results. With me today from Innospec are Patrick Williams, President and Chief Executive Officer; and Ian Cleminson, Executive Vice President and Chief Financial Officer. And with that, I'll turn it over to you, Patrick.

    Patrick Williams President and Chief Executive Officer Thank you, David, and welcome, everyone, to Innospec's Third Quarter 2026 Conference Call. This was a strong quarter for Innospec, with all businesses delivering sales growth and operating income improvement. Performance Chemicals sales growth and gross margin improvement drove an 84% operating income increase over last year. The North Carolina plant efficiency upgrades discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity, and yields on a wide range of existing personal care and other products. In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters. Fuel Specialties had another strong quarter, delivering revenue and operating income growth with margins in our target range. Both volume and price/mix improved as the business has continued to manage well against raw material volatility. We expect continued strong performance and seasonal demand in the coming quarters. Oilfield Services operating income grew 40% and operating margins expanded, driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected due to activity delays in our Middle East legacy business, along with elevated raw material costs. We expect sequential improvement in the fourth quarter. Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments.

    Frequently Asked Questions About IOSP

    When is Innospec's next earnings date?

    Innospec's next earnings report is expected for Feb 15, 2027.

    Did IOSP beat earnings estimates last quarter?

    Yes. Innospec reported EPS of $1.29 for the quarter ended Sep 30, 2026, above the $1.26 estimate, a 2.38% surprise.

    What EPS do analysts expect from IOSP next quarter?

    The consensus EPS estimate for Innospec for the quarter ending Dec 31, 2026 is $1.45 from 5 analysts, with estimates from $1.35 to $1.52.

    How often does IOSP beat earnings estimates?

    Innospec beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +7.72%.